As the job market continues to evolve, the cost of living, salaries, and benefits are all rising globally. This quick evolution presents a difficult challenge for hiring managers and HR reps who want ...
Millions could be entitled to compensation as a result of commission arrangements between lenders and dealers.
Physician compensation is slightly increasing, but Medicare cuts and Advantage plan shifts may impact income and employment models. Nurse practitioners are projected to grow by 40% from 2023 to 2033, ...
Jeffrey Johnson has written novels and movies in addition to legal analyses of eminent domain and immigration law. His experience in writing engaging fiction makes him uniquely capable of making the ...
January 07, 2025 - 2024 was a busy year for officials in state regulatory agencies and legislatures as they addressed workers' compensation rates and laws in an effort to reduce costs for employers, ...
Forbes contributors publish independent expert analyses and insights. Dr. Shulman provides expertise on entrepreneurial wealth creation. Executive compensation has long been a topic of scrutiny and ...
Looking for the best compensation management software? Check out our top picks and find the perfect solution for your business. With compensation management software, businesses can better assess ...
The issues addressed below will be explored further at a February 15 event featuring two authors of this Forefront article (Saini and Brownlee) as well as Health Affairs Editor-in-Chief Alan Weil and ...
J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. Anthony ...
Base salary is the money you pay your exempt employees for doing their jobs. Exempt employees are those whose jobs require them to routinely exercise independent judgement in their work. They're paid ...
The Covid-19 pandemic has triggered a global vaccine race. As of September 27, 2020, there were more than 200 vaccine candidates in preclinical and clinical development, including 11 in phase 3 trials ...